{"acquisitions":[],"changes":[],"country":"US","description":"Drug discovery company developing oral small-molecule therapies for obesity and metabolic disease via GPCR targets. Targets pharma partners and metabolic-disease patients underserved by peptide GLP-1s. Differentiates with structure-based discovery combining cryo-EM, biophysical assays, and AI molecular design.","domain":"ambrosiabiosciences.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":40.102555,"lng":-105.363208,"location":"Boulder CO","multiples":[],"name":"Ambrosia Biosciences","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":100000000,"connectionsAmong":[],"currency":"USD","date":"2026-04-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"ambrosiabiosciences-com-2026-04-01-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"ambrosiabiosciences-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"ambrosiabiosciences.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://ambrosiabiosciences.com"},{"fact":"description","publisher":"ambrosiabiosciences.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://ambrosiabiosciences.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress 6.9.4","jQuery Migrate 3.4.1","Popper","Cloudflare Bot Management","Vercel Speed Insights","web-vitals","PHP","MySQL","jquery 3.7.1","bootstrap 5.3.2"],"totalRaisedUsd":150000000,"traction":[],"updatedAt":"2026-05-02","valuations":[]}